SunTrust Banks, Inc. began coverage on shares of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) in a report issued on Monday, May 22nd, MarketBeat reports. The brokerage issued a buy rating and a $26.00 price target on the stock.
Separately, Stifel Nicolaus began coverage on Verona Pharma PLC American Depositary Share in a report on Monday, May 22nd. They set a buy rating and a $22.00 price objective for the company.
Shares of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) traded up 2.35% on Monday, hitting $12.64. The stock had a trading volume of 4,376 shares. Verona Pharma PLC American Depositary Share has a one year low of $11.05 and a one year high of $17.50. The company’s market cap is $81.15 million. The firm’s 50-day moving average is $13.65 and its 200-day moving average is $13.65.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2017/06/16/verona-pharma-plc-american-depositary-share-vrna-research-coverage-started-at-suntrust-banks-inc-updated-updated.html.
Receive News & Ratings for Verona Pharma PLC American Depositary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma PLC American Depositary Share and related companies with MarketBeat.com's FREE daily email newsletter.